Skip to Content

SGX943 Approval Status

FDA Approved: No
Brand name: SGX943
Generic name: dusquetide
Company: Soligenix, Inc.
Treatment for: Melioidosis

SGX943 (dusquetide) is an Innate Defense Regulator (IDR) in development for the treatment of melioidosis.

Development Status and FDA Approval Process for SGX943

DateArticle
May 31, 2016FDA Grants Soligenix “Fast Track” Designation for SGX943 for the Treatment of Melioidosis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide